Abstract
Tuberculosis remains a major global public health challenge. Although incidence is decreasing, the proportion of drug-resistant cases is increasing. Technical and operational complexities prevent Mycobacterium tuberculosis drug susceptibility phenotyping in the vast majority of new and retreatment cases. The advent of molecular technologies provides an opportunity to obtain results rapidly as compared to phenotypic culture. However, correlations between genetic mutations and resistance to multiple drugs have not been systematically evaluated. Molecular testing of M. tuberculosis sampled from a typical patient continues to provide a partial picture of drug resistance. A database of phenotypic and genotypic testing results, especially where prospectively collected, could document statistically significant associations and may reveal new, predictive molecular patterns. We examine the feasibility of integrating existing molecular and phenotypic drug susceptibility data to identify associations observed across multiple studies and demonstrate potential for well-integrated M. tuberculosis mutation data to reveal actionable findings.
References
May 16, 2008·FEMS Immunology and Medical Microbiology·Amita Jain, Rajesh Mondal
Feb 13, 2009·PLoS Medicine·Andreas SandgrenMegan B Murray
Sep 10, 2010·The New England Journal of Medicine·Catharina C BoehmeMark D Perkins
Feb 9, 2011·Antimicrobial Agents and Chemotherapy·Patricia J CampbellJames E Posey
Jan 27, 2012·The Journal of Antimicrobial Chemotherapy·Fernanda MaruriAlexandra Aubry
Feb 2, 2012·Genome Research·Nicola CasaliFrancis Drobniewski
Feb 4, 2012·Journal of Clinical Microbiology·Pawan K AngraJohn C Ridderhof
Apr 6, 2012·PloS One·Sophia B GeorghiouTimothy C Rodwell
Sep 29, 2012·Journal of Medical Microbiology·Elena Yu NosovaArkadyi M Moroz
Dec 26, 2012·Tuberculosis·David Stucki, Sebastien Gagneux
Oct 16, 2013·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·G-L JiangK M Kam
Dec 20, 2013·Journal of Clinical Microbiology·Timothy C RodwellAntonino Catanzaro
Jan 31, 2014·Journal of Clinical Microbiology·S-Y Grace LinEdward P Desmond
Aug 15, 2014·The New England Journal of Medicine·James T LuBrendan H Lee
Oct 23, 2014·MBio·Paolo MiottoDaniela M Cirillo
Citations
Jul 3, 2015·EBioMedicine·Madhukar Pai
Dec 3, 2015·EBioMedicine·Marco Schito, David L Dolinger
Oct 23, 2016·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Kiatichai FaksriRick Twee-Hee Ong
May 5, 2017·PloS One·Sayera BanuEric R Houpt
Mar 15, 2015·The Journal of Infectious Diseases·Madhukar Pai, Marco Schito
May 18, 2017·Scandinavian Journal of Immunology·P Méndez-Samperio
Jun 21, 2017·Antimicrobial Agents and Chemotherapy·Arfatur RahmanSayera Banu
Mar 17, 2017·Journal of Clinical Microbiology·Robyn S Lee, Madhukar Pai
Aug 1, 2018·Antimicrobial Agents and Chemotherapy·Tomasz JagielskiJarosław Dziadek
Dec 30, 2017·The European Respiratory Journal·Paolo MiottoTimothy C Rodwell
Oct 28, 2016·Nature Reviews. Disease Primers·Madhukar PaiMario Raviglione
Aug 16, 2016·PloS One·Kiatichai FaksriAngkana Chaiprasert
Dec 7, 2019·AAPS PharmSciTech·Patricia MarcianesAna Fernández-Carballido
May 26, 2017·PloS One·Darwin J OperarioEric R Houpt
Oct 20, 2018·Scientific Reports·Matthew EzewudoJames Posey
Dec 24, 2018·MSystems·A S GargisD Sue
May 8, 2016·Pharmaceutical Research·Michael A CollierKristy M Ainslie
May 10, 2020·PloS One·Mazhgan RownekiDavid Alland
Oct 21, 2016·Microbiology Spectrum·Madhukar PaiCatharina C Boehme